微管相关蛋白tau转基因细胞和动物模型的建立及tau蛋白病变表征

doi:10.3969/j.issn.1006-7795.2019.04.017

首都医科大学学报 ›› 2019, Vol. 40 ›› Issue (4): 582-587.doi: 10.3969/j.issn.1006-7795.2019.04.017

• 神经系统退行性疾病的基础研究 • 上一篇下一篇

微管相关蛋白tau转基因细胞和动物模型的建立及tau蛋白病变表征

马登磊^1,2,3, 张旭^2,4, 罗艺^1,2,3, 黄蕊^1,2,3, 李雅莉^1,2,3, 李林^1,2,3, 张兰^1,2,3

1. 首都医科大学宣武医院药学部, 北京 100053;
2. 神经变性病教育部重点实验室, 北京 100053;
3. 北京市神经药物工程研究中心, 北京 100053;
4. 首都医科大学宣武医院中心实验室, 北京 100053

收稿日期:2019-05-15 出版日期:2019-07-21 发布日期:2019-07-19
通讯作者: 张兰 E-mail:lanizhg@126.com
基金资助:
国家自然科学基金（81473373，81874351，81673406），国家重大新药创制专项（2015ZX09101－016），北京市高层次卫生技术人才（2011－1－7，2014－2－014）。

Establishment and characterization of microtubule-associated protein tau over-expression cell and transgenic animal models

Ma Denglei^1,2,3, Zhang Xu^2,4, Luo Yi^1,2,3, Huang Rui^1,2,3, Li Yali^1,2,3, Li Lin^1,2,3, Zhang Lan^1,2,3

1. Department of Pharmacy, Xuanwu Hospital, Capital Medical University, Beijing 100053, China;
2. Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing 100053, China;
3. Beijing Engineering Research Center for Nerve System Drugs, Beijing 100053, China;
4. Central Laboratory, Xuanwu Hospital, Capital Medical University, Beijing 100053, China

Received:2019-05-15 Online:2019-07-21 Published:2019-07-19
Supported by:
This study was supported by National Natural Science Foundation of China (81473373,81874351,81673406), National Science and Technology Major Project of China (2015ZX09101-016), Beijing High-level Health and Technical Personal Plan (2011-1-7,2014-2-014).

摘要/Abstract

摘要： 目的构建并表征tau及突变tau蛋白细胞和动物模型，检测模型tau蛋白及磷酸化tau蛋白表达情况及微管的形态，为tau蛋白及相关疾病的研究提供疾病模型。方法将不同的质粒分别转染到HEK293细胞中，构建过表达野生型tau以及P301L/P301S突变tau的细胞模型。引进并繁育rTg4510小鼠（P301L突变tau转基因小鼠）以及PS19小鼠（P301S突变tau转基因小鼠）。通过Western blotting法检测总tau及磷酸化tau蛋白的表达，应用免疫组织化学的方法检测转基因小鼠脑内磷酸化tau蛋白的表达情况，应用免疫荧光的方法检测HEK293细胞微管形态的变化。结果本研究成功构建过表达tau蛋白的细胞模型，繁育了两种tau转基因小鼠，在这些模型中tau蛋白表达及tau蛋白的磷酸化水平显著高于对照组。在不同突变类型的细胞和动物模型中，tau蛋白不同位点的磷酸化水平变化以及微管形态变化略有差异。结论本研究成功构建了P301L/P301S突变tau蛋白的细胞和动物模型，这些模型均表现了显著的tau蛋白过度磷酸化的病变，并引起了细胞微管形态或tau蛋白病理的变化，进而为包括AD在内的tau蛋白病变提供了实验模型。

关键词: 微管相关蛋白tau, 细胞转染模型, 转基因动物模型, 微管

Abstract: Objective To construct and characterize tau and mutant tau protein cell and animal models. Methods Different plasmids were transfected into HEK293 cells,and cell models overexpressing wild-type tau or P301L/P301S mutant tau were constructed. rTg4510 mice (P301L mutant tau transgenic mice) and PS19 mice (P301S mutant tau transgenic mice) were introduced and bred. The expression of total tau and phosphorylated tau protein was detected with Western blotting. The expression of phosphorylated tau protein in the brain of transgenic mice was detected with immunohistochemistry. The morphology of HEK293 cells was observed with immunofluorescence. Results In this study,cell and animal models overexpressing tau were successfully constructed. The tau protein expression in these models were significantly increased,and the phosphorylation levels of tau protein were significantly higher than that of the control group. In the cell and animal models of different mutation types,changes in phosphorylation levels and microtubule morphology at different sites showed slight differences. Conclusion We successfully constructed P301L/P301S mutant tau cell and animal models with significant tau hyperphosphorylation and changes in cell microtubule morphology. These models might provide alternative for proper disease model in the studies of tau and tauopathies,such as Alzheimer's disease.

Key words: microtubule -associated protein tau, transfected cell model, transgenic animal model, microtubule

中图分类号:

R592

马登磊, 张旭, 罗艺, 黄蕊, 李雅莉, 李林, 张兰. 微管相关蛋白tau转基因细胞和动物模型的建立及tau蛋白病变表征[J]. 首都医科大学学报, 2019, 40(4): 582-587.

Ma Denglei, Zhang Xu, Luo Yi, Huang Rui, Li Yali, Li Lin, Zhang Lan. Establishment and characterization of microtubule-associated protein tau over-expression cell and transgenic animal models[J]. Journal of Capital Medical University, 2019, 40(4): 582-587.

参考文献 17

[1]	Liu C W,Lee G,Jay D G. Tau is required for neurite outgrowth and growth cone motility of chick sensory neurons[J]. Cell Motil Cytoskeleton,1999,43(3):232-242.
[2]	Iqbal K,Del C. Alonso A,et al. Tau pathology in Alzheimer disease and other tauopathies[J]. Biochim Biophys Acta,2005,1739(2-3):198-210.
[3]	王建枝,田青. Tau蛋白过度磷酸化机制及其在阿尔茨海默病神经元变性中的作用[J]. 生物化学与生物物理进展,2012,8:771-777.
[4]	Noble W,Hanger D P,Gallo J M. Transgenic mouse models of tauopathy in drug discovery[J]. CNS Neurol Disord Drug Targets,2010,9(4):403-428.
[5]	米东华,张本恕,马爱军. 连锁于17号染色体伴帕金森病的额颞叶痴呆[J]. 国际遗传学杂志,2007,30(1):72-75.
[6]	马登磊,张如意,李林. P301L突变tau蛋白转基因动物模型及其应用[J]. 中国比较医学杂志,2018,28(1):123-128.
[7]	马登磊,张兰. P301S突变tau转基因动物模型及其应用[J]. 实验动物与比较医学,2017,37(6):491-496.
[8]	SantaCruz K,Lewis J,Spires T,et al. Tau suppression in a neurodegenerative mouse model improves memory function[J]. Science,2005,309(5733):476-481.
[9]	Yoshiyama Y,Higuchi M,Zhang B,et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model[J]. Neuron,2007,53(3):337-351.
[10]	Šimi AčX G,Babi AčX Leko M,Wray S,et al. Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's disease and other tauopathies,and possible neuroprotective strategies[J]. Biomolecules,2016,6(1):6.
[11]	Iqbal K,Liu F,Gong C X. Tau and neurodegenerative disease:the story so far[J]. Nat Rev Neurol,2016,12(1):15-27.
[12]	Chang E,Kim S,Schafer K N,et al. Pseudophosphorylation of tau protein directly modulates its aggregation kinetics[J]. Biochim Biophys Acta,2011,1814(2):388-395.
[13]	Iqbal K,Gong C X,Liu F. Hyperphosphorylation-induced tau oligomers[J]. Front Neurol,2013,4:112.
[14]	Alonso A D C,Mederlyova A,Novak M,et al. Promotion of hyperphosphorylation by frontotemporal dementia tau mutations[J]. J Biol Chem,2004,279(33):34873-34881.
[15]	Dujardin S,Colin M,Buée L. Invited review:Animal models of tauopathies and their implications for research/translation into the clinic[J]. Neuropathol Appl Neurobiol,2015,41(1):59-80.
[16]	Kaufman S K,Sanders D W,Thomas T L,et al. Tau prion strains dictate patterns of cell pathology,progression rate,and regional vulnerability in vivo[J]. Neuron,2016,92(4):796-812.
[17]	杨翠翠, 李林,张丽,等.马钱苷通过抑制蛋白磷酸酶2A催化亚基C磷酸化降低tau蛋白过度磷酸化[J].首都医科大学学报,2016,37(6):789-793.

微管相关蛋白tau转基因细胞和动物模型的建立及tau蛋白病变表征

Establishment and characterization of microtubule-associated protein tau over-expression cell and transgenic animal models

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 17

相关文章 5

编辑推荐

Metrics

本文评价

[1]	王蔚, 苏嘉明, 袁东波, 张伟, 陈卫红, 孙兆林, 朱建国. 微管相关蛋白1A在前列腺癌中的表达与其临床特征的关系[J]. 首都医科大学学报, 2019, 40(1): 65-71.
[2]	陈宁, 王珊珊, 陈玉涵, 殷继明, 陈德喜, 丁惠国. 外源性硫化氢对肝癌细胞系HepG2自噬的影响[J]. 首都医科大学学报, 2015, 36(1): 116-120.
[3]	刘光伟;李瑛;李昕;李尧华;于顺. α-突触核蛋白促进MES23.5细胞突起生长[J]. 首都医科大学学报, 2011, 32(6): 759-763.
[4]	吴杨;苏玉金;李昕;刘光伟;李尧华;于顺. α-突触核蛋白在人脑膜瘤组织中的表达[J]. 首都医科大学学报, 2011, 32(6): 793-797.
[5]	历俊华;万虹;王忠诚. 免疫荧光染色检测不同组织细胞微管蛋白-β的表达[J]. 首都医科大学学报, 2004, 25(1): 57-59.